Zhejiang Shouxiangu Pharm Co
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the selection, cultivation, processing, and sale of medicinal materials in China. It offers Ganoderma lucidum spore powder and brand broken cell wall powder, as well as broken wall Ganoderma lucidum spore powder granules and powder tablets; Tiepi Fengdou granules; and Tiepi Fengdou Ganoderma lucidum extracts. The company offers its products … Read more
Zhejiang Shouxiangu Pharm Co (603896) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.009x
Based on the latest financial reports, Zhejiang Shouxiangu Pharm Co (603896) has a cash flow conversion efficiency ratio of 0.009x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥20.94 Million) by net assets (CN¥2.31 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Shouxiangu Pharm Co - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Zhejiang Shouxiangu Pharm Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Shouxiangu Pharm Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Shouxiangu Pharm Co ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DONGGUAN R.COMMERC. H YC1
F:857
|
N/A |
|
Jiangsu Tongli Risheng Machinery Co. Ltd.
SHG:605286
|
-0.069x |
|
Hanza AB
ST:HANZA
|
0.034x |
|
Thai Vegetable Oil Public Company Limited
BK:TVO
|
-0.048x |
|
Lindex Group
HE:LINDEX
|
-0.015x |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
|
0.012x |
|
Facc AG
VI:FACC
|
0.002x |
|
Alpargatas S.A
SA:ALPA3
|
0.031x |
Annual Cash Flow Conversion Efficiency for Zhejiang Shouxiangu Pharm Co (2012–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Shouxiangu Pharm Co from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.29 Billion | CN¥213.44 Million | 0.093x | -35.88% |
| 2023-12-31 | CN¥2.17 Billion | CN¥315.06 Million | 0.145x | -18.98% |
| 2022-12-31 | CN¥1.91 Billion | CN¥341.28 Million | 0.179x | -2.21% |
| 2021-12-31 | CN¥1.62 Billion | CN¥296.70 Million | 0.183x | -5.25% |
| 2020-12-31 | CN¥1.33 Billion | CN¥256.36 Million | 0.193x | +9.00% |
| 2019-12-31 | CN¥1.17 Billion | CN¥207.92 Million | 0.177x | +1.82% |
| 2018-12-31 | CN¥984.74 Million | CN¥171.51 Million | 0.174x | +36.71% |
| 2017-12-31 | CN¥869.75 Million | CN¥110.80 Million | 0.127x | -41.72% |
| 2016-12-31 | CN¥436.93 Million | CN¥95.52 Million | 0.219x | -5.25% |
| 2015-12-31 | CN¥368.53 Million | CN¥85.03 Million | 0.231x | -28.12% |
| 2014-12-31 | CN¥320.56 Million | CN¥102.90 Million | 0.321x | +45.99% |
| 2013-12-31 | CN¥299.50 Million | CN¥65.85 Million | 0.220x | -32.93% |
| 2012-12-31 | CN¥138.37 Million | CN¥45.36 Million | 0.328x | -- |